Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

February 28, 2011

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

LISTER ROBERT D

2. Issuer Name and Ticker or Trading Symbol
IMAX CORP [IMAX]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
Chief Legal & Sr Exec VP

(Last)

(First)

(Middle)

902 BROADWAY, 20TH FLOOR

3. Date of Earliest Transaction (Month/Day/Year)
03/07/2024

(Street)

NEW YORK, NY 10010-6002

4. If Amendment, Date Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
common shares (opening balance)								134,618	D
common shares	03/07/2024		M		14,733 ⁽¹⁾	A	$ 0	149,351	D
common shares	03/07/2024		M		11,957 ⁽¹⁾	A	$ 0	161,308	D
common shares	03/07/2024		M		12,957 ⁽¹⁾	A	$ 0	174,265	D
common shares	03/07/2024		F		21,129 ⁽²⁾	D	$ 16.8	153,136	D
common shares	03/07/2024		A		22,856 ⁽³⁾	A	$ 0	175,992	D
common shares	03/07/2024		F		12,103 ⁽⁴⁾	D	$ 16.8	163,889	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

restricted share units ⁽⁵⁾

$ 0 ⁽⁶⁾

03/07/2024

14,733 ⁽¹⁾

⁽⁷⁾

common shares

14,733

$ 0 ⁽⁶⁾

0 ⁽¹⁰⁾

restricted share units ⁽⁵⁾

$ 0 ⁽⁶⁾

03/07/2024

11,957 ⁽¹⁾

⁽⁸⁾

common shares

11,957

$ 0 ⁽⁶⁾

11,959 ⁽¹⁰⁾

restricted share units ⁽⁵⁾

$ 0 ⁽⁶⁾

03/07/2024

12,957 ⁽¹⁾

⁽⁹⁾

common shares

12,957

$ 0 ⁽⁶⁾

25,916 ⁽¹⁰⁾

restricted share units ⁽⁵⁾

$ 0 ⁽⁶⁾

03/07/2024

42,975

⁽⁷⁾

common shares

42,975

$ 0 ⁽⁶⁾

42,975 ⁽¹⁰⁾

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
LISTER ROBERT D 902 BROADWAY 20TH FLOOR NEW YORK, NY 10010-6002			Chief Legal & Sr Exec VP

Signatures

/s/ Kenneth I. Weissman (attorney-in-fact for Robert D. Lister)		03/11/2024
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Represents the conversion upon vesting of restricted share units into common shares.
(2)	Mr. Lister is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the restricted share unit transactions.
(3)	Represents the conversion of vested performance stock units into common shares granted by the Company on March 7, 2021. The shares earned are based on the level of achievement on the EBITDA performance conditions over the three year performance period.
(4)	Mr. Lister is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the performance share unit transactions.
(5)	Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.
(6)	Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.
(7)	The restricted share units vest and will be converted to common shares in three equal installments on each of the first three anniversaries of the grant date.
(8)	The restricted share units vest and will be converted to common shares in three installments: 11,957 on each of March 7, 2023 and March 7, 2024 and 11,959 on March 7, 2025.
(9)	The restricted share units vest and will be converted to common shares in three installments: 12,957 on each of March 7, 2024 and March 7, 2025 and 12,959 March 7, 2026.
(10)	This represents the number of restricted share units for this transaction only. Mr. Lister's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 106,053, 80,850 and 163,889, respectively. The number of outstanding options reflects the expiration of options to purchase 39,909 common shares on March 7, 2024. Mr. Lister did not receive any value in connection with such expiration; therefore, such expiration is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, under Rule 16b-6(d).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.